+142
New
142
Positions
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | SOCIETE GENERALE | N/A | Apr 2024 | 5,299,000 | $5.3M | 5.61% | RA |
| 2 | Natwest Markets PLC | N/A | Apr 2024 | 4,451,000 | $4.5M | 4.71% | RA |
| 3 | CREDIT AGRICOLE CIB NY | N/A | Apr 2024 | 4,239,000 | $4.2M | 4.49% | RA |
| 4 | AGPXX | 825252885 | Apr 2024 | 2,264,947 | $2.3M | 2.40% | STIV |
| 5 | ROYAL BANK OF CANADA | N/A | Apr 2024 | 2,119,000 | $2.1M | 2.24% | RA |
| 6 | ALPINE IMMUNE SCIENCES, INC. | 02083G100 | Apr 2024 | 22,422 | $1.4M | 1.53% | EC |
| 7 | HSBC SECURITIES USA INC | N/A | Apr 2024 | 1,377,000 | $1.4M | 1.46% | RA |
| 8 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 27,175 | $1.0M | 1.07% | EC |
| 9 | Immunitybio Inc | 45256X103 | Apr 2024 | 125,229 | $1.0M | 1.06% | EC |
| 10 | Viking Therapeutics Inc | 92686J106 | Apr 2024 | 12,209 | $972K | 1.03% | EC |
| 11 | MODERNA, INC. | 60770K107 | Apr 2024 | 8,507 | $938K | 0.99% | EC |
| 12 | EXELIXIS, INC. | 30161Q104 | Apr 2024 | 39,459 | $926K | 0.98% | EC |
| 13 | NATERA, INC. | 632307104 | Apr 2024 | 9,841 | $914K | 0.97% | EC |
| 14 | Crinetics Pharmaceuticals Inc | 22663K107 | Apr 2024 | 20,724 | $908K | 0.96% | EC |
| 15 | CEREVEL THERAPEUTICS HOLDINGS, INC. | 15678U128 | Apr 2024 | 21,246 | $907K | 0.96% | EC |
| 16 | GERON CORPORATION | 374163103 | Apr 2024 | 230,432 | $906K | 0.96% | EC |
| 17 | PTC THERAPEUTICS, INC. | 69366J200 | Apr 2024 | 28,126 | $904K | 0.96% | EC |
| 18 | Roivant Sciences Ltd | G76279101 | Apr 2024 | 82,060 | $894K | 0.95% | EC |
| 19 | SAREPTA THERAPEUTICS, INC. | 803607100 | Apr 2024 | 7,046 | $892K | 0.94% | EC |
| 20 | AMGEN INC. | 031162100 | Apr 2024 | 3,201 | $877K | 0.93% | EC |
| 21 | BLUEPRINT MEDICINES CORPORATION | 09627Y109 | Apr 2024 | 9,494 | $867K | 0.92% | EC |
| 22 | EXACT SCIENCES CORPORATION | 30063P105 | Apr 2024 | 14,597 | $866K | 0.92% | EC |
| 23 | NEUROCRINE BIOSCIENCES, INC. | 64125C109 | Apr 2024 | 6,295 | $866K | 0.92% | EC |
| 24 | UNITED THERAPEUTICS CORPORATION | 91307C102 | Apr 2024 | 3,607 | $845K | 0.89% | EC |
| 25 | BIOGEN INC. | 09062X103 | Apr 2024 | 3,926 | $843K | 0.89% | EC |
| 26 | ALNYLAM PHARMACEUTICALS, INC. | 02043Q107 | Apr 2024 | 5,850 | $842K | 0.89% | EC |
| 27 | Dyne Therapeutics Inc | 26818M108 | Apr 2024 | 32,912 | $833K | 0.88% | EC |
| 28 | VERTEX PHARMACEUTICALS INCORPORATED | 92532F100 | Apr 2024 | 2,119 | $832K | 0.88% | EC |
| 29 | Rhythm Pharmaceuticals Inc | 76243J105 | Apr 2024 | 20,896 | $831K | 0.88% | EC |
| 30 | BIOMARIN PHARMACEUTICAL INC. | 09061G101 | Apr 2024 | 10,197 | $824K | 0.87% | EC |
| 31 | IONIS PHARMACEUTICALS, INC. | 462222100 | Apr 2024 | 19,923 | $822K | 0.87% | EC |
| 32 | CYTOKINETICS, INCORPORATED | 23282W605 | Apr 2024 | 13,330 | $817K | 0.86% | EC |
| 33 | REGENERON PHARMACEUTICALS, INC. | 75886F107 | Apr 2024 | 904 | $805K | 0.85% | EC |
| 34 | SpringWorks Therapeutics Inc | 85205L107 | Apr 2024 | 17,157 | $801K | 0.85% | EC |
| 35 | HALOZYME THERAPEUTICS, INC. | 40637H109 | Apr 2024 | 21,002 | $800K | 0.85% | EC |
| 36 | ABBVIE INC. | 00287Y109 | Apr 2024 | 4,900 | $797K | 0.84% | EC |
| 37 | IDEAYA Biosciences Inc | 45166A102 | Apr 2024 | 19,236 | $782K | 0.83% | EC |
| 38 | Krystal Biotech Inc | 501147102 | Apr 2024 | 5,100 | $781K | 0.83% | EC |
| 39 | INSMED INCORPORATED | 457669307 | Apr 2024 | 31,502 | $779K | 0.82% | EC |
| 40 | BRIDGEBIO PHARMA, INC. | 10806X102 | Apr 2024 | 30,241 | $775K | 0.82% | EC |
| 41 | GILEAD SCIENCES, INC. | 375558103 | Apr 2024 | 11,666 | $761K | 0.80% | EC |
| 42 | INCYTE CORPORATION | 45337C102 | Apr 2024 | 14,602 | $760K | 0.80% | EC |
| 43 | Immunovant Inc | 45258J102 | Apr 2024 | 27,655 | $759K | 0.80% | EC |
| 44 | DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | Apr 2024 | 66,697 | $758K | 0.80% | EC |
| 45 | VERICEL CORPORATION | 92346J108 | Apr 2024 | 16,472 | $756K | 0.80% | EC |
| 46 | IRONWOOD PHARMACEUTICALS, INC. | 46333X108 | Apr 2024 | 97,269 | $754K | 0.80% | EC |
| 47 | Syndax Pharmaceuticals Inc | 87164F105 | Apr 2024 | 35,669 | $754K | 0.80% | EC |
| 48 | Ultragenyx Pharmaceutical Inc | 90400D108 | Apr 2024 | 17,344 | $738K | 0.78% | EC |
| 49 | ALKERMES PUBLIC LIMITED COMPANY | G01767105 | Apr 2024 | 29,963 | $735K | 0.78% | EC |
| 50 | Vaxcyte Inc | 92243G108 | Apr 2024 | 12,057 | $730K | 0.77% | EC |
| 51 | Twist Bioscience Corp | 90184D100 | Apr 2024 | 23,327 | $729K | 0.77% | EC |
| 52 | Nuvalent Inc | 670703107 | Apr 2024 | 10,386 | $715K | 0.76% | EC |
| 53 | TG THERAPEUTICS, INC. | 88322Q108 | Apr 2024 | 52,228 | $713K | 0.75% | EC |
| 54 | AMICUS THERAPEUTICS, INC. | 03152W109 | Apr 2024 | 71,251 | $712K | 0.75% | EC |
| 55 | MADRIGAL PHARMACEUTICALS, INC. | 558868105 | Apr 2024 | 3,433 | $700K | 0.74% | EC |
| 56 | CATALYST PHARMACEUTICALS, INC. | 14888U101 | Apr 2024 | 46,519 | $700K | 0.74% | EC |
| 57 | NOVAVAX, INC. | 670002401 | Apr 2024 | 160,657 | $696K | 0.74% | EC |
| 58 | Agios Pharmaceuticals Inc | 00847X104 | Apr 2024 | 21,140 | $687K | 0.73% | EC |
| 59 | CELLDEX THERAPEUTICS, INC. | 15117B202 | Apr 2024 | 18,293 | $685K | 0.72% | EC |
| 60 | Kymera Therapeutics Inc | 501575104 | Apr 2024 | 20,152 | $678K | 0.72% | EC |
| 61 | ROCKET PHARMACEUTICALS, INC. | 77313F106 | Apr 2024 | 31,412 | $676K | 0.72% | EC |
| 62 | Vera Therapeutics Inc | 92337R101 | Apr 2024 | 16,704 | $660K | 0.70% | EC |
| 63 | Iovance Biotherapeutics Inc | 462260100 | Apr 2024 | 55,821 | $658K | 0.70% | EC |
| 64 | Inhibrx Inc | 45720L107 | Apr 2024 | 19,300 | $657K | 0.70% | EC |
| 65 | Arcutis Biotherapeutics Inc | 03969K108 | Apr 2024 | 78,600 | $654K | 0.69% | EC |
| 66 | Ardelyx Inc | 039697107 | Apr 2024 | 100,852 | $645K | 0.68% | EC |
| 67 | Keros Therapeutics Inc | 492327101 | Apr 2024 | 11,421 | $644K | 0.68% | EC |
| 68 | Denali Therapeutics Inc | 24823R105 | Apr 2024 | 41,563 | $642K | 0.68% | EC |
| 69 | MIRUM PHARMACEUTICALS, INC. | 604749101 | Apr 2024 | 25,447 | $639K | 0.68% | EC |
| 70 | APELLIS PHARMACEUTICALS, INC. | 03753U106 | Apr 2024 | 14,220 | $628K | 0.66% | EC |
| 71 | INTELLIA THERAPEUTICS, INC. | 45826J105 | Apr 2024 | 29,242 | $626K | 0.66% | EC |
| 72 | ACADIA PHARMACEUTICALS INC. | 004225108 | Apr 2024 | 37,388 | $625K | 0.66% | EC |
| 73 | BIOCRYST PHARMACEUTICALS, INC. | 09058V103 | Apr 2024 | 150,019 | $620K | 0.66% | EC |
| 74 | Recursion Pharmaceuticals Inc | 75629V104 | Apr 2024 | 78,319 | $612K | 0.65% | EC |
| 75 | Arcellx Inc | 03940C100 | Apr 2024 | 12,114 | $606K | 0.64% | EC |
| 76 | UMB FINANCIAL CORP | N/A | Apr 2024 | 601,000 | $601K | 0.64% | RA |
| 77 | ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | Apr 2024 | 26,201 | $593K | 0.63% | EC |
| 78 | Prothena Corporation PLC | G72800108 | Apr 2024 | 29,001 | $590K | 0.62% | EC |
| 79 | CRISPR Therapeutics AG | H17182108 | Apr 2024 | 11,104 | $588K | 0.62% | EC |
| 80 | Biohaven Ltd | G1110E107 | Apr 2024 | 15,118 | $587K | 0.62% | EC |
| 81 | Kura Oncology Inc | 50127T109 | Apr 2024 | 29,747 | $584K | 0.62% | EC |
| 82 | Veracyte Inc | 92337F107 | Apr 2024 | 29,488 | $577K | 0.61% | EC |
| 83 | Morphic Holding Inc | 61775R105 | Apr 2024 | 21,101 | $575K | 0.61% | EC |
| 84 | Protagonist Therapeutics Inc | 74366E102 | Apr 2024 | 22,861 | $574K | 0.61% | EC |
| 85 | Akero Therapeutics Inc | 00973Y108 | Apr 2024 | 28,097 | $559K | 0.59% | EC |
| 86 | ALTIMMUNE, INC. | 02155H200 | Apr 2024 | 84,350 | $552K | 0.58% | EC |
| 87 | Deciphera Pharmaceuticals Inc | 24344T101 | Apr 2024 | 20,857 | $527K | 0.56% | EC |
| 88 | SAGE THERAPEUTICS, INC. | 78667J108 | Apr 2024 | 37,502 | $523K | 0.55% | EC |
| 89 | Viridian Therapeutics Inc | 92790C104 | Apr 2024 | 39,076 | $518K | 0.55% | EC |
| 90 | C4 Therapeutics Inc | 12529R107 | Apr 2024 | 79,672 | $502K | 0.53% | EC |
| 91 | MacroGenics Inc | 556099109 | Apr 2024 | 33,748 | $499K | 0.53% | EC |
| 92 | Beam Therapeutics Inc | 07373V105 | Apr 2024 | 23,352 | $496K | 0.52% | EC |
| 93 | Arcus Biosciences Inc | 03969F109 | Apr 2024 | 32,461 | $494K | 0.52% | EC |
| 94 | Biomea Fusion Inc | 09077A106 | Apr 2024 | 45,715 | $491K | 0.52% | EC |
| 95 | Scholar Rock Holding Corp | 80706P103 | Apr 2024 | 33,043 | $485K | 0.51% | EC |
| 96 | MYRIAD GENETICS, INC. | 62855J104 | Apr 2024 | 23,804 | $466K | 0.49% | EC |
| 97 | Avidity Biosciences Inc | 05370A108 | Apr 2024 | 19,206 | $463K | 0.49% | EC |
| 98 | Xencor Inc | 98401F105 | Apr 2024 | 21,921 | $459K | 0.49% | EC |
| 99 | Soleno Therapeutics Inc | 834203309 | Apr 2024 | 10,144 | $453K | 0.48% | EC |
| 100 | Cogent Biosciences Inc | 19240Q201 | Apr 2024 | 67,314 | $438K | 0.46% | EC |
| 101 | Sana Biotechnology Inc | 799566104 | Apr 2024 | 47,394 | $427K | 0.45% | EC |
| 102 | ADMA BIOLOGICS, INC. | 000899104 | Apr 2024 | 65,201 | $425K | 0.45% | EC |
| 103 | EDITAS MEDICINE, INC. | 28106W103 | Apr 2024 | 77,015 | $401K | 0.42% | EC |
| 104 | Replimune Group Inc | 76029N106 | Apr 2024 | 61,361 | $390K | 0.41% | EC |
| 105 | AVID BIOSERVICES, INC. | 05368M106 | Apr 2024 | 50,228 | $383K | 0.41% | EC |
| 106 | Arcturus Therapeutics Holdings Inc | 03969T109 | Apr 2024 | 14,965 | $383K | 0.40% | EC |
| 107 | 89Bio Inc | 282559103 | Apr 2024 | 44,181 | $376K | 0.40% | EC |
| 108 | Cabaletta Bio Inc | 12674W109 | Apr 2024 | 33,871 | $361K | 0.38% | EC |
| 109 | 4D Molecular Therapeutics Inc | 35104E100 | Apr 2024 | 14,867 | $356K | 0.38% | EC |
| 110 | Vir Biotechnology Inc | 92764N102 | Apr 2024 | 41,985 | $355K | 0.38% | EC |
| 111 | Apogee Therapeutics Inc | 03770N101 | Apr 2024 | 6,320 | $318K | 0.34% | EC |
| 112 | Day One Biopharmaceuticals Inc | 23954D109 | Apr 2024 | 18,452 | $316K | 0.33% | EC |
| 113 | Zentalis Pharmaceuticals Inc | 98943L107 | Apr 2024 | 28,479 | $315K | 0.33% | EC |
| 114 | TRAVERE THERAPEUTICS, INC. | 89422G107 | Apr 2024 | 56,883 | $315K | 0.33% | EC |
| 115 | Relay Therapeutics Inc | 75943R102 | Apr 2024 | 44,348 | $289K | 0.31% | EC |
| 116 | MANNKIND CORPORATION | 56400P706 | Apr 2024 | 69,966 | $288K | 0.30% | EC |
| 117 | Olema Pharmaceuticals Inc | 68062P106 | Apr 2024 | 28,164 | $286K | 0.30% | EC |
| 118 | FATE THERAPEUTICS, INC. | 31189P102 | Apr 2024 | 69,729 | $275K | 0.29% | EC |
| 119 | Disc Medicine Inc | 254604101 | Apr 2024 | 9,830 | $274K | 0.29% | EC |
| 120 | CAREDX, INC. | 14167L103 | Apr 2024 | 34,862 | $271K | 0.29% | EC |
| 121 | Regenxbio Inc | 75901B107 | Apr 2024 | 17,190 | $264K | 0.28% | EC |
| 122 | Kiniksa Pharmaceuticals Ltd | G5269C101 | Apr 2024 | 13,462 | $252K | 0.27% | EC |
| 123 | Cullinan Oncology Inc | 230031106 | Apr 2024 | 9,275 | $251K | 0.27% | EC |
| 124 | Verve Therapeutics Inc | 92539P101 | Apr 2024 | 41,243 | $248K | 0.26% | EC |
| 125 | Summit Therapeutics Inc | 86627T108 | Apr 2024 | 62,146 | $244K | 0.26% | EC |
| 126 | Nurix Therapeutics Inc | 67080M103 | Apr 2024 | 20,205 | $243K | 0.26% | EC |
| 127 | Anavex Life Sciences Corp | 032797300 | Apr 2024 | 64,025 | $234K | 0.25% | EC |
| 128 | AnaptysBio Inc | 032724106 | Apr 2024 | 8,667 | $211K | 0.22% | EC |
| 129 | Allogene Therapeutics Inc | 019770106 | Apr 2024 | 75,090 | $207K | 0.22% | EC |
| 130 | Caribou Biosciences Inc | 142038108 | Apr 2024 | 51,744 | $188K | 0.20% | EC |
| 131 | MIMEDX GROUP, INC. | 602496101 | Apr 2024 | 27,549 | $170K | 0.18% | EC |
| 132 | Tango Therapeutics Inc | 87583X109 | Apr 2024 | 21,027 | $162K | 0.17% | EC |
| 133 | Astria Therapeutics Inc | 04635X102 | Apr 2024 | 14,959 | $137K | 0.15% | EC |
| 134 | Alector Inc | 014442107 | Apr 2024 | 26,339 | $134K | 0.14% | EC |
| 135 | Mersana Therapeutics Inc | 59045L106 | Apr 2024 | 35,210 | $112K | 0.12% | EC |
| 136 | Oric Pharmaceuticals Inc | 68622P109 | Apr 2024 | 10,622 | $94K | 0.10% | EC |
| 137 | ARS Pharmaceuticals Inc | 82835W108 | Apr 2024 | 10,662 | $93K | 0.10% | EC |
| 138 | Voyager Therapeutics Inc | 92915B106 | Apr 2024 | 11,393 | $89K | 0.09% | EC |
| 139 | CARGO Therapeutics Inc | 14179K101 | Apr 2024 | 4,548 | $87K | 0.09% | EC |
| 140 | AVITA Medical Inc | 05380C102 | Apr 2024 | 4,932 | $41K | 0.04% | EC |
| 141 | TOTAL RETURN SWAP AGREEMENT BASED ON THE | N/A | Apr 2024 | 5,084 | $-93506 | -0.10% | DE |
| 142 | TOTAL RETURN SWAP AGREEMENT BASED ON THE | N/A | Apr 2024 | 4,761 | $-210961 | -0.22% | DE |